This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend DPC

If you would like more information on diabetes care, please refer to the NHS website.

Visit the NHS website?

DPC2021 Conference Programme

IMAGE

Loading

Polypharmacy in diabetes prescribing

10 Nov 2021
Workshop 2

This interactive session will aim to illustrate the importance of deprescribing in polypharmacy and individualisation of diabetes therapy optimisation. We will bring in real-life case studies to highlight the practicalities and application of guideline recommendations taking into account patient factors and co-morbidities.
Learning Outcomes: - Understand the impact of deprescribing in polypharmacy in people with diabetes. - Gain an awareness of up-to-date

  • - Understand the impact of deprescribing in polypharmacy in people with diabetes. - Gain an awareness of up-to-date diabetes medicines optimisation guideline recommendations, in particular in those with type 2 diabetes and frailty or at high cardiovascular risk. - Able to apply guideline recommendations in individuals with multi-morbid diabetes.

Sponsors

Diamond Sponsor

  • AstraZeneca

 

Platinum Sponsor

  • Abbott

 

Platinum Sponsor

  • Dexcom

 

Platinum Sponsor

  • Novo Nordisk

 

Platinum Sponsor

  • Viatris

 

Gold Sponsor

  • Eli Lilly

 

Gold Sponsor

  • Insulet

 

Silver Sponsor

  • Sanofi

 

Registration Sponsor

  • Viatris